Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
Fred Hutch Cancer Center – Proton Therapy lung cancer specialist John Kang, MD, PhD, recently attended the American Society for Radiation Oncology (ASTRO) conference in Seattle.
“My students presented research that examined outcomes of protons versus photons in lung cancer patients treated at our center between 2018 and 2024,”
he said. The research found that both modalities had similar toxicities, but protons allowed us to treat tumors that were 25-30% larger in volume with similar outcomes.
Scientists expect more toxicities and side effects with bulkier tumors, including pneumonitis and esophagitis as well as future cardiac events. Larger tumors are also generally considered more advanced and deadlier.
Author's summary: New research on proton therapy for lung cancer has promising results.